Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of November 14, 2025 • 10:01 PM ET

Date/Time Source News Release
11/14/2025 04:05 PM EST GlobeNewswire Entera Bio Announces Third Quarter 2025 Financial Results and Business Updates
10/23/2025 08:50 AM EDT GlobeNewswire Entera Bio Presents Positive New Clinical Data from EB613 Phase 2 Trial Demonstrating Significant Bone Density Improvements in Early Postmenopausal Women
10/16/2025 08:45 AM EDT GlobeNewswire Entera Bio to Present New Clinical Data from Phase 2 Trial of EB613 at the 2025 North American Menopause Society (NAMS) Annual Meeting
09/15/2025 09:00 AM EDT GlobeNewswire Entera Bio Reports Positive PK Data for First-in-Class Oral GLP-2 Tablet Treatment for Patients with Short Bowel Syndrome at the 2025 ESPEN Congress
09/08/2025 08:30 AM EDT GlobeNewswire Entera Bio Presents Positive Effects of EB613 on Both Trabecular and Cortical Bone in Postmenopausal Women with Osteoporosis at ASBMR 2025
08/28/2025 08:00 AM EDT GlobeNewswire Entera Bio to Unveil Clinical and Non-Clinical Data Across 3 Oral Peptide Programs at Upcoming September Conferences
08/08/2025 04:05 PM EDT GlobeNewswire Entera Bio Announces Second Quarter 2025 Financial Results and Business Updates
07/28/2025 07:30 AM EDT GlobeNewswire Entera Bio Receives FDA Agreement on BMD as Primary Endpoint for EB613 Registrational, Phase 3 Study in Post-Menopausal Women with Osteoporosis
07/08/2025 08:00 AM EDT GlobeNewswire OPKO Health and Entera Bio Announce Abstract on PK/PD of Oral GLP-2 Tablet for the Treatment of Short Bowel Syndrome Selected for 2025 ESPEN Congress
06/26/2025 08:00 AM EDT GlobeNewswire Entera Bio Data for EB613 Effects on Trabecular and Cortical Bone in Post-Menopausal Women with Osteoporosis Selected for Oral Presentation at ASBMR 2025 Annual Meeting
Page

Additional News

As of November 14, 2025 • 10:01 PM ET

Date/Time Source News Release
11/14/2025 04:50 PM EST SeekingAlpha Entera Bio GAAP EPS of $0.07
11/14/2025 06:00 AM EST US Earnings Reports Expected US Company Earnings on Friday, November 14th, 2025
11/14/2025 04:30 AM EST US Earnings Reports Expected earnings - Entera Bio Ltd.
11/13/2025 05:42 PM EST KlickAnalytics ENTX - Historical Price Movements Surrounding Earnings
11/13/2025 05:37 PM EST KlickAnalytics ENTX - Historical Earnings Price Analysis
09/18/2025 08:41 AM EDT Zacks Entera Bio Unveils Promising PK Data for First Oral GLP-2 Therapy
08/11/2025 04:32 AM EDT SeekingAlpha Entera Bio GAAP EPS of -$0.06 beats by $0.10
08/08/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Friday, August 8th, 2025
08/08/2025 05:31 AM EDT US Earnings Reports Expected earnings - Entera Bio Ltd.
08/07/2025 06:45 PM EDT KlickAnalytics ENTX - Historical Price Movements Surrounding Earnings
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.